Results 61 to 70 of about 4,816,902 (277)
Australian Journal of Social Issues, EarlyView.ABSTRACT Children in out‐of‐home care (OOHC) frequently present with complex behavioural needs. In New South Wales (NSW), behaviour support plans (BSPs) are mandated when restrictive practices, including psychotropic medication, are used. Little research has examined whether the statutory workforce is adequately prepared to meet behaviour support ...
Manisha Abayakoon Stanborough +4 more
wiley +1 more source
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
, 2022 Hepatology, EarlyView.
Robert J. Fontana +6 more
wiley +1 more source
Focus on Cognitive Enhancement: A Narrative Overview of Nootropics and “Smart Drug” Use and Misuse
BiologyWhilst “nootropics” are meant to treat a range of medical disorder-related cognitive impairments, the typically healthy “smart drugs” user ingests a range of drugs/molecules to achieve improved mental performance.
Fabrizio Schifano +6 more
doaj +1 more source
Brain Sciences, 2018 Substance misuse services need to meet the growing demand and needs of individuals using new psychoactive substances (NPS). A review of the literature identified a paucity of research regarding NPS use by these individuals and UK guidelines outline the ...
Rosalind Gittins +3 more
doaj +1 more source
Psychoactive substances in secure mental health settings. [PDF]
, 2017 New Psychoactive Substances (NPS) are a group of drugs that are designed to replicate the effects of other illegal substances. People use them for experimental, recreational purposes and some may become dependent on them. NPS usually fall into one of the
Maddalena, Nino, Smith, Sarah, Day, Matt
core
Cortical Thickness and White Matter Surface Morphology in Tourette Syndrome: A Cohort Study
Annals of Neurology, EarlyView.Objective To examine cortical thickness and white matter surface morphology in a large sample of individuals with Tourette syndrome (TS) and neurotypical controls across the lifespan, and to assess associations with symptom severity, comorbidities, and medication use.
Sahar Delavari +8 more
wiley +1 more source
Novel Psychoactive Spectra: NMR of (mostly) Novel Psychoactive Substances [PDF]
, 2017 1H NMR spectra of classical and novel psychoactive substances (NPS) are reported, including phenylethanamines (2-phenylethan-1-amines), phenylpropanamines (1-phenylpropan-2-amines), N-benzyl-phenylalkanamines, β-keto-phenylalkanamines (2-amino-1-phenylethan-1-ones and 2-amino-1-phenylpropan-1-ones), thiophenylpropanamines (1-(thiophen-2-yl)propan ...
openaire +1 more source
Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users. [PDF]
, 2013 There have been several recent efforts in the UK and the Netherlands to describe the harms of psychoactive substances based on ratings of either experts or drug users.
Noronha, LA +4 more
core
Autism Research, EarlyView.ABSTRACT Antidepressant prescribing and autism diagnoses have increased in recent years. We aimed to describe and compare trends in antidepressant prescribing, indications, doses and durations in autistic and non‐autistic males and females in the United Kingdom (UK) from 1997 to 2023.
Aws Sadik +7 more
wiley +1 more source
Neurochemical profiles of some novel psychoactive substances
European Journal of Pharmacology, 2013 Fourteen substances from the class of drugs sometimes known as “legal highs” were screened against a battery of human receptors in binding assays, and their potencies as inhibitors of monoamine uptake determined in functional in vitro assays. Thirteen of the test substances acted as inhibitors of monoamine uptake at submicromolar concentrations ...
Iversen, Les +5 more
openaire +4 more sources